Techno Trends
TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.
Dizal Launches First-in-class Golidocitinib Inhibitor for Relapsed or Refractory Peripheral T-Cell Lymphoma
Dizal has introduced golidocitinib as a pioneering treatment specifically for adult patients suffering from relapsed or refractory peripheral T-cell lymphoma, a form of aggressive non-Hodgkin lymphoma
Cranbury Pharmaceuticals Introduces First-of-its-kind Emflaza® for Duchenne Muscular Dystrophy (DMD)
Cranbury Pharmaceuticals has introduced a groundbreaking product, Emflaza® oral suspension, designed specifically for treating Duchenne muscular dystrophy
Loma Linda University Health Developed First-of-its-kind Gene Therapy for Hemophilia
Loma Linda University Health has achieved a groundbreaking milestone with the development of a pioneering gene therapy for hemophilia B, complemented by dirloctocogene samoparvovec, an advanced
Spinogenix Discovered SPG302, a Novel Therapy for the Treatment of Amyotrophic lateral sclerosis (ALS)
Spinogenix has discovered a novel treatment, SPG302, for Amyotrophic Lateral Sclerosis. SPG302 is a once-daily pill developed as a regenerative therapy for ALS
UC San Diego Health Introduced Novel Therapy for Melanoma
UC San Diego Health has unveiled a pioneering immunotherapy treatment for metastatic melanoma, heralding a breakthrough in cancer care. This novel approach utilises personalised cellular therapy
Vera Therapeutics Launches Breakthrough Atacicept Therapy for Immunoglobulin A Nephropathy
Vera Therapeutics has introduced Atacicept, a breakthrough therapy for Immunoglobulin A Nephropathy (IgAN). Atacicept is an investigational recombinant fusion protein that incorporates the soluble
Biogen Develops QALSODY®, the First Therapy to Treat a Rare, Genetic Form of ALS
Biogen has developed QALSODY®, a groundbreaking therapy for adults with amyotrophic lateral sclerosis linked to a mutation in the superoxide dismutase 1 gene
Merus Develops Novel Petosemtamab for the Treatment of Head and Neck Squamous Cell Carcinoma (HNSCC)
Merus has introduced a pioneering treatment called petosemtamab, tailored for patients grappling with recurrent or metastatic head and neck squamous cell carcinoma that has advanced despite prior treatment
Roche Introduced Inavolisib for the Treatment of HER2-negative Breast Cancer
Roche has introduced inavolisib, an oral investigational therapy, combined with palbociclib and fulvestrant, for treating adult patients with PIK3CA-mutated, hormone receptor-positive, HER2-negative
Amgen Introduces First and Only IMDELLTRA™ T-Cell Engager Therapy for Small Cell Lung Cancer
Amgen has introduced IMDELLTRA™, the first and only T-cell engager therapy for treating extensive-stage small cell lung cancer. IMDELLTRA™ is unique as the only DLL3-targeting bispecific T-cell engager therapy
